Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Free Cash Flow: 2023-2024

Historic Free Cash Flow for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to -$78.9 million.

  • CG Oncology's Free Cash Flow fell 144.95% to -$39.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$117.1 million, marking a year-over-year decrease of 61.06%. This contributed to the annual value of -$78.9 million for FY2024, which is 72.83% down from last year.
  • Per CG Oncology's latest filing, its Free Cash Flow stood at -$78.9 million for FY2024, which was down 72.83% from -$45.7 million recorded in FY2023.
  • In the past 5 years, CG Oncology's Free Cash Flow ranged from a high of -$45.7 million in FY2023 and a low of -$78.9 million during FY2024.
  • Moreover, its 2-year median value for Free Cash Flow was -$62.3 million (2023), whereas its average is -$62.3 million.
  • Data for CG Oncology's Free Cash Flow shows a maximum YoY plummeted of 72.83% (in 2024) over the last 5 years.
  • CG Oncology's Free Cash Flow (Yearly) stood at -$45.7 million in 2023, then slumped by 72.83% to -$78.9 million in 2024.